Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jun 23:2:16043.
doi: 10.1038/nrdp.2016.43.

Uterine fibroids

Elizabeth A Stewart  1 , Shannon K Laughlin-Tommaso  1 , William H Catherino  2 , Sujata Lalitkumar  3 , Devashana Gupta  4   5   6 , Beverley Vollenhoven  4   5   6
Affiliations
Review

Uterine fibroids

Elizabeth A Stewart et al. Nat Rev Dis Primers. .

Abstract

Uterine fibroids (also known as leiomyomas or myomas) are common clonal neoplasms of the uterus. Fibroids have both smooth muscle and fibroblast components, in addition to a substantial amount of fibrous extracellular matrix, which all contribute to the pathogenetic process. Fibroids are extremely heterogeneous in their pathophysiology, size, location and clinical symptomatology. They are also a part of a range of disease in which some variants have facets of malignant behaviour but overall are benign. Risk for fibroids is associated with race; black women have a higher risk of developing fibroids earlier in life than their white counterparts and also develop more-severe forms of the disease. Clinically, fibroids account for one-third to half of all hysterectomies and are associated with substantial morbidity and health care costs for women of reproductive age. Indeed, current treatments are primarily surgical and interventional; approximately three-quarters of all fibroid treatments are hysterectomies. However, clinical innovations are emerging in the use of progesterone receptor modulators as a medical therapy. New information is rapidly accumulating about the genetic subgroups that lead to fibroid formation, which might aid further understanding of the clinical heterogeneity of this disease and lead to individualized treatments. This information is a crucial development given the current lack of high-quality evidence on which to base therapeutic decisions.

PubMed Disclaimer

Similar articles

  • Therapeutic management of uterine fibroid tumors.
    Puchar A, Feyeux C, Luton D, Koskas M. Puchar A, et al. Minerva Ginecol. 2016 Aug;68(4):466-76. Epub 2015 Dec 23. Minerva Ginecol. 2016. PMID: 26698838 Review.
  • The management of uterine fibroids in women with otherwise unexplained infertility.
    Carranza-Mamane B, Havelock J, Hemmings R; REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY COMMITTEE; SPECIAL CONTRIBUTOR. Carranza-Mamane B, et al. J Obstet Gynaecol Can. 2015 Mar;37(3):277-285. doi: 10.1016/S1701-2163(15)30318-2. J Obstet Gynaecol Can. 2015. PMID: 26001875
  • The management of uterine leiomyomas.
    Vilos GA, Allaire C, Laberge PY, Leyland N; SPECIAL CONTRIBUTORS. Vilos GA, et al. J Obstet Gynaecol Can. 2015 Feb;37(2):157-178. doi: 10.1016/S1701-2163(15)30338-8. J Obstet Gynaecol Can. 2015. PMID: 25767949
  • Therapeutic management of uterine fibroid tumors: updated French guidelines.
    Marret H, Fritel X, Ouldamer L, Bendifallah S, Brun JL, De Jesus I, Derrien J, Giraudet G, Kahn V, Koskas M, Legendre G, Lucot JP, Niro J, Panel P, Pelage JP, Fernandez H; CNGOF (French College of Gynecology and Obstetrics). Marret H, et al. Eur J Obstet Gynecol Reprod Biol. 2012 Dec;165(2):156-64. doi: 10.1016/j.ejogrb.2012.07.030. Epub 2012 Aug 29. Eur J Obstet Gynecol Reprod Biol. 2012. PMID: 22939241 Review.
  • Uterine fibroids.
    Stewart EA. Stewart EA. Lancet. 2001 Jan 27;357(9252):293-8. doi: 10.1016/S0140-6736(00)03622-9. Lancet. 2001. PMID: 11214143 Review.
See all similar articles

Cited by

See all "Cited by" articles

LinkOut - more resources

-